TrialJournal of digestive diseases2022

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial.

Li Hua Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.